Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Tessmer James F
Relationship:   VP, Finance & Accounting
City:   The Woodlands
State:   TX
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   71,766    

Indirect Shares

  0      
Direct Value   $122,002    

Indirect Value

  $0      
Total Shares   71,766      
Total Value   $122,002      


Lexicon Pharmaceuticals Inc
 $122,002 Lexicon Pharmaceuticals Inc
 $122,002
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -33.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Lexicon Pharmaceuticals Inc LXRX VP, Finance & Accounting 2021-03-15 71,766 0    Premium*  
* Premium Members only  

Records found :    38         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2018-06-08 4 OE $10.15 $101,500 D/D 10,000 35,643 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2019-02-28 4 D $5.51 $13,781 D/D (2,501) 33,368 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2019-02-28 4 OE $0.00 $0 D/D 10,226 35,869 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2019-08-02 4 B $1.14 $11,400 D/D 10,000 43,368 2.74 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2020-02-28 4 OE $0.00 $0 D/D 16,396 59,764 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2020-02-28 4 D $2.77 $10,809 D/D (3,902) 55,862 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2020-04-22 4 A $0.00 $0 D/D 13,262 69,124 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2020-04-22 4 D $1.96 $7,834 D/D (3,997) 65,127 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2021-02-28 4 OE $0.00 $0 D/D 28,316 93,443 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2021-02-28 4 D $7.19 $77,400 D/D (10,765) 82,678 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2021-03-15 4 OE $3.31 $39,720 D/D 12,000 83,766 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2021-03-15 4 S $6.90 $158,440 D/D (22,912) 71,766 0 %
LXRX Lexicon Pharmaceuticals I... VP, Finance & AcctgOfficer   •       –      –    2008-04-29 3 IO $0.00 $0 D/D 0 1,700 -

  38  Records found
  1   2     
  Page 2 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed